FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?
In Brief: Ginder To direct Massey Cancer Center; UAB Receives $1 Million for Genetics Chair
National Action Plan: Steering committee Votes No Confidence In HHS Official.
Professional Societies: Tobacco Industry Should Pay For Research, AACR Says
Federal Funding: IOM Report Praises DOD Breast Cancer Research Program
NCI RFA Available: Minority-Based CCOPS
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ









